4Nacearelli GV, Dougherty AH. Amiodarone SW. A review of its pharmacologic antiarrhythrnie and adverse effects. In: Podrid P J, Kowey P R, eds. Cardiac arrhythmia: Mechanisms , diagnosis, and management. Baltimore: Williams & Wilkins, 1995. 434.
5Burkart F, Pfisterer M, Kiowski W, et at. Effect of antiarrhyth- mic therapy on mortality on survivors of myocardial infarction with symptomatic complex ventrieular arrhythmias: basel arrhythmic: basel arrhythmie stady of infact swrvial. J Am coll cardiol, 1990. 16:1711.
6Cairns JA, Connolly SJ, Roberts RS, et al. Canadian Amiodarone Myocardial Infarction Arrhythmia Trial Invesgators. Randomized trial of outcome ofter myocardial infarction in patients with frequent or repetitive ventricular premature depolarization: CAMIT. Lancet, 1999,353:9.
7Amiodarone Trials Meta-Analysis Invesgators. Effect of prophylactic amiodarone on mortality after acute myocardial infarction and in congestive heart failure: metaanalysis of individual data from 6500 patients in randomised trials. Lancet, 1997, 350: 1417.
8Kndenchuk PJ, Cabb LA, Copass MK, et al. Amiodarone for resuscitation after out-of-hospital cardiac arrest due to ventricular fibrillation. N Engl reed, 1999,341:871.
8Jie X, Gurev V, Trayanova N. Mechanisms of mechani- cally in duced spontaneous arrhythmias in acute regional ischemia[J]. Cir Res,2010,106 (1) :158-192.
9Gomes V, Brando V, Mimoso J, et al. Implementation of a pre -hospital network favoring primary angioplasty in STEMI to reduce mortality., the Algarve Project [J]. Rev Port Cardiol,2012,31(3) : 193-201.
10Kajikawa Y, Ikeda M, Takemoto S, et al. Association of circulating levels of leptin and adiponectin with meta- bolic syndrome and coronary heart disease in patients with various coronary risk factors[J]. Im Heart J, 2011, 52:17-22.
